Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75
Published August 26, 2020 · Recall initiated: August 10, 2020
Summary
FDA records drug Class II recall D-1507-2020, published August 26, 2020 and initiated August 10, 2020. Recalling firm: Sanofi-Aventis U.S. LLC; Status: Ongoing; Reported quantity: 7451 vials; Lot: Lot #: A9306, Exp 2/28/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if ELITEK has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ELITEK
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Distributor
- Nationwide in the US
- Lot
- Lot #: A9306, Exp 2/28/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASTIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, ManufacturedAugust 26, 2020
- FDAPrednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PAAugust 26, 2020
- FDADesmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for:August 26, 2020
- FDABD ChloraPrep Clear 3 mL Applicators (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcoholAugust 26, 2020
- FDADDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: FerringAugust 26, 2020
- FDAChloraPrep With Tint (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) 3 mLAugust 26, 2020
Questions about this recall
Was Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75 recalled?
Yes. FDA published recall D-1507-2020 on August 26, 2020. Reported hazard: Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ELITEK.